2023.01.10

Value of the intellectual property portfolio of Genomtec S.A. estimated at EUR 191.336 million

Genomtec S.A. received from the German company Dennemeyer Consulting GmbH a valuation of the Company’s intellectual property portfolio. ...
2022.11.30

Genomtec S.A. signs an agreement with transaction advisor Clairfield Partners LLC

Genomtec S.A., a medical technology company specializing in the development of advanced technologies in the field of genetic diagnostics, has ...
2022.08.10

Genomtec wins a new partner to commercialize the Genomtec® ID platform in Taiwan (R.O.C.).

Genomtec has signed up a new Partner for the commercialization of its flagship Genomtec® ID genetic testing platform and the Respiratory Panel ...
2022.07.11

Genomtec appoints new Chief Technology Officer

Genomtec has appointed Richard Moore as the new Chief Technology Officer to drive its next generation of products and systems. Richard replaces ...
2022.06.27

Genomtec continues to add distributors for its flagship Genomtec®ID platform product and genetic respiratory tests in Europe

Genomtec has secured an additional distributor for its Gentomec®ID portable testing platform and RP5-PLEX panel for detecting respiratory tract ...
2022.06.08

Genomtec®ID Respiratory Panel 5-Plex (RP5-PLEX) for the detection of respiratory tract infections has received CE-IVD certification as the only solution of its kind in Europe

Genomtec has obtained the CE-IVD mark for its flagship solution, the Genomtec®ID Respiratory Panel 5-Plex (RP5-PLEX) diagnostic panel for the ...